Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
Authors:
Preprint
Abstract
A high-resolution understanding of the antibody response to SARS-CoV-2 is important for the design of effective diagnostics, vaccines and therapeutics. However, SARS-CoV-2 antibody epitopes remain largely uncharacterized, and it is unknown whether and how the response may cross-react with related viruses. Here, we use a multiplexed peptide assay (‘PepSeq’) to generate an epitope-resolved view of reactivity across all human coronaviruses. PepSeq accurately detects SARS-CoV-2 exposure and resolves epitopes across the Spike and Nucleocapsid proteins. Two of these represent recurrent reactivities to conserved, functionally-important sites in the Spike S2 subunit, regions that we show are also targeted for the endemic coronaviruses in pre-pandemic controls. At one of these sites, we demonstrate that the SARS-CoV-2 response strongly and recurrently cross-reacts with the endemic virus hCoV-OC43. Our analyses reveal new diagnostic and therapeutic targets, including a site at which SARS-CoV-2 may recruit common pre-existing antibodies and with the potential for broadly-neutralizing responses.Keywords
All Related Versions
- Published version: Cell Reports Medicine, 2 (1), 100189.
This publication has 57 references indexed in Scilit:
- Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory DiseaseScience Translational Medicine, 2013
- On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactionsNature Medicine, 2012
- A Highly Scalable Peptide-Based Assay System for ProteomicsPLOS ONE, 2012
- New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage AssayPLOS ONE, 2012
- Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in SerumClinical and Vaccine Immunology, 2010
- Multiple Nucleic Acid Binding Sites and Intrinsic Disorder of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein: Implications for Ribonucleocapsid Protein PackagingJournal of Virology, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Human Coronavirus NL63 and 229E Seroconversion in ChildrenJournal of Clinical Microbiology, 2008
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977